AtriCure, Inc.Long
ATRC BUY 45.06$ SL 40$
May-08-20 08:47AM AtriCure Announces Results from CONVERGE IDE Clinical Trial Business Wire +7.70%
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.